ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IMRSQ Imris Inc (CE)

0.000001
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Imris Inc (CE) USOTC:IMRSQ OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.000001 0.00 01:00:00

Report of Foreign Issuer (6-k)

11/09/2014 2:50pm

Edgar (US Regulatory)


 


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2014

Commission File Number: 001-34975

IMRIS INC.
(Translation of registrant's name into English)

100-1370 Sony Place, Winnipeg, Manitoba, Canada R3T 1N5
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨


 

 
 

 

 

DOCUMENTS FILED AS PART OF THIS FORM 6-K

 

See the Exhibit Index hereto.

 


 
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


  IMRIS Inc.
  (Registrant)
     
Date: September 11, 2014 By: /s/ Jay D. Miller
 

_____________________________________

  Name: Jay D. Miller
  Title: President, Chief Executive Officer and Director
     

 


 
 

 

EXHIBIT INDEX

99.1 News Release dated September 11, 2014 - IMRIS neurosurgical HFD rocker arm receives FDA clearance

 

 


 



Exhibit 99.1

 

 

IMRIS neurosurgical HFD rocker arm receives FDA clearance

Photo_Asset_1

Head fixation device (HFD) accessory provides skull stabilization for more patient head sizes

MINNEAPOLIS, Sept. 11, 2014 /CNW/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced a new rocker arm accessory that expands choices for neurosurgeons to select the best fixation suited for patients during procedures using intraoperative imaging inside the VISIUS Surgical Theatre. The accessory recently received 510(k) clearance from the U.S. Food and Drug Administration.

The new rocker arm accessory provides more flexibility for the surgeon to stabilize, support and position patient heads with varying cranial anatomy, sizes and conditions using the MRI-compatible IMRIS HFD. When attached to the head fixation device (HFD) - a clamp-like device - the rocker arm helps to reduce the pressure on the individual contact points on the patient's skull.

"Providing these optimal tools for neurosurgeons will allow more patients to benefit from the value of diagnostic quality imaging in the operating room with VISIUS iMR," said Jay D. Miller, IMRIS President and CEO. "The development of the rocker arm is an example of IMRIS' ability to design products and features that allow neurosurgeons to use intraoperative MR inside the VISIUS Surgical Theatre for an expanding patient population."

Inside a VISIUS Surgical Theatre equipped with high-field intraoperative MRI (iMRI), surgeons have on-demand access to real-time diagnostic quality imaging during the procedure and from the operating room table as the scanner uniquely moves to the patient on ceiling-mounted rails. The IMRIS HFDs support the unique ability to limit patient movement or re-positioning and maintain optimal positioning for both surgical access and intraoperative imaging during neurosurgical procedures.

The VISIUS iMRI provides neurosurgeons the ability to assess and decide to perform further resection for removing as much tumor as possible by clearly visualizing tumor and healthy brain tissue which otherwise are hard to differentiate.

About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by 61 leading medical institutions around the world.

 

SOURCE IMRIS Inc.

Image with caption: "The IMRIS neurosurgical MRI-compatible head fixation device now has a rocker arm accessory to expand patient population. (CNW Group/IMRIS Inc.)". Image available at: http://photos.newswire.ca/images/download/20140911_C8925_PHOTO_EN_42751.jpg

%CIK: 0001489161

For further information:

Kevin J. Berger
Marketing Communications Manager
IMRIS Inc.
Tel: 763-203-6332
Email: kberger@imris.com

CO: IMRIS Inc.

CNW 08:00e 11-SEP-14

1 Year Imris (CE) Chart

1 Year Imris (CE) Chart

1 Month Imris (CE) Chart

1 Month Imris (CE) Chart

Your Recent History

Delayed Upgrade Clock